These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38452647)

  • 1. Seizures in inflammatory demyelinating disorders of the central nervous system.
    Ertürk Çetin Ö; Güngör Doğan İ; Zanapalioğlu Ü; Yadi F; Çetinkaya Tezer D; Demir S
    Mult Scler Relat Disord; 2024 May; 85():105535. PubMed ID: 38452647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seizures and epilepsy in multiple sclerosis, aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder, and myelin oligodendrocyte glycoprotein antibody-associated disease.
    Li EC; Zheng Y; Cai MT; Lai QL; Fang GL; Du BQ; Shen CH; Zhang YX; Wu LJ; Ding MP
    Epilepsia; 2022 Sep; 63(9):2173-2191. PubMed ID: 35652436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder.
    Camera V; Holm-Mercer L; Ali AAH; Messina S; Horvat T; Kuker W; Leite MI; Palace J
    JAMA Netw Open; 2021 Dec; 4(12):e2137833. PubMed ID: 34878547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature.
    Nagireddy RBR; Kumar A; Singh VK; Prasad R; Pathak A; Chaurasia RN; Mishra VN; Joshi D
    J Neuroimmunol; 2021 Dec; 361():577742. PubMed ID: 34655992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epileptic seizures in Japanese patients with multiple sclerosis and neuromyelitis optica.
    Nakano H; Tanaka M; Kinoshita M; Tahara M; Matsui M; Tanaka K; Konishi T
    Epilepsy Res; 2013 Mar; 104(1-2):175-80. PubMed ID: 23000513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromyelitis optica IgG serostatus in fulminant central nervous system inflammatory demyelinating disease.
    Magaña SM; Pittock SJ; Lennon VA; Keegan BM; Weinshenker BG; Lucchinetti CF
    Arch Neurol; 2009 Aug; 66(8):964-6. PubMed ID: 19667216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seropositive Neuromyelitis Optica in a Case of Undiagnosed Ankylosing Spondylitis: A Neuro-Rheumatological Conundrum.
    Ghosh Md R; Roy D; León-Ruiz M; Das S; Dubey S; Benito-León J
    Qatar Med J; 2022; 2022(3):29. PubMed ID: 35864917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunological differences between MOG associated disease and anti AQP4 antibody-positive neuromyelitis optica spectrum disorders: Blood-brain barrier breakdown and peripheral plasmablasts.
    Tanaka S; Hashimoto B; Izaki S; Oji S; Fukaura H; Nomura K
    Mult Scler Relat Disord; 2020 Jun; 41():102005. PubMed ID: 32114369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internuclear Ophthalmoplegia Characterizes Multiple Sclerosis Rather Than Neuromyelitis Optica Spectrum Disease.
    Hamza MM; Alas BF; Huang C; Quon JC; Amezcua L; Robers MV; Gokoffski KK
    J Neuroophthalmol; 2022 Jun; 42(2):239-245. PubMed ID: 35427281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT).
    Samadzadeh S; Adnan R; Berglova P; Barzegar M; Debrabant B; Roikjaer SG; Levy M; Petzold A; Palace J; Flanagan EP; Mariotto S; Skou ST; Froelich A; Lotan I; Messina S; Geraldes R; Asseyer S; Stiebel-Kalish H; Oertel FC; Shaygannejad V; Sahraian MA; Kim HJ; Bennett JL; Böttcher C; Zimmermann HG; Weinshenker BG; Paul F; Asgari N
    Front Immunol; 2024; 15():1380025. PubMed ID: 39021565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
    Bauer A; Rudzki D; Berek K; Dinoto A; Lechner C; Wendel EM; Hegen H; Deisenhammer F; Berger T; Höftberger R; Rostasy K; Mariotto S; Reindl M
    Front Immunol; 2022; 13():1037812. PubMed ID: 36451827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system inflammatory demyelinating disorders among Hong Kong Chinese.
    Chan KH; Lee R; Lee JC; Tse AC; Pang SY; Lau GK; Teo KC; Ho PW
    J Neuroimmunol; 2013 Sep; 262(1-2):100-5. PubMed ID: 23838529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and Safety of Rituximab in Central Nervous System Demyelinating Disorders.
    Patil VA; Kamat SN; Lalkaka JA; Singhal B
    Ann Indian Acad Neurol; 2021; 24(5):732-739. PubMed ID: 35002132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex and gender differences in autoimmune demyelinating CNS disorders: Multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD) and myelin-oligodendrocyte-glycoprotein antibody associated disorder (MOGAD).
    Diem L; Hammer H; Hoepner R; Pistor M; Remlinger J; Salmen A
    Int Rev Neurobiol; 2022; 164():129-178. PubMed ID: 36038203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and laboratory features distinguishing MOG antibody disease from multiple sclerosis and AQP4 antibody-positive neuromyelitis optica.
    Ciotti JR; Eby NS; Wu GF; Naismith RT; Chahin S; Cross AH
    Mult Scler Relat Disord; 2020 Oct; 45():102399. PubMed ID: 32702642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) in Chile: lessons learned from challenging cases.
    Guzmán J; Vera F; Soler B; Uribe-San-Martin R; García L; Del-Canto A; Schlatter A; Salazar M; Molt F; Ramirez K; Marín J; Pelayo C; Cruz JP; Bravo-Grau S; Cárcamo C; Ciampi E
    Mult Scler Relat Disord; 2023 Jan; 69():104442. PubMed ID: 36521387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin, China.
    Yang CS; Zhang DQ; Wang JH; Jin WN; Li MS; Liu J; Zhang CJ; Li T; Shi FD; Yang L
    CNS Neurosci Ther; 2014 Jan; 20(1):32-9. PubMed ID: 23890015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Typical and atypical optic neuritis].
    Sheremet NL; Eliseeva DD; Kalashnikova AK; Zakharova MN
    Vestn Oftalmol; 2023; 139(6):175-182. PubMed ID: 38235645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis.
    Molazadeh N; Akaishi T; Bose G; Nishiyama S; Chitnis T; Levy M
    Mult Scler Relat Disord; 2023 Dec; 80():105093. PubMed ID: 37949025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seizures and epilepsy in multiple sclerosis: epidemiology and prognosis in a large tertiary referral center.
    Langenbruch L; Krämer J; Güler S; Möddel G; Geßner S; Melzer N; Elger CE; Wiendl H; Budde T; Meuth SG; Kovac S
    J Neurol; 2019 Jul; 266(7):1789-1795. PubMed ID: 31069528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.